IP Library Granted Patent US 10,978,214
Granted Patent B2
US 10,978,214 · App. 13/575,826 · Granted Apr 13, 2021

Segmented reaction chamber for radioisotope production

Inventors: Gregory Piefer (Middleton, WI); Thomas Rockwell Mackie (Verona, WI)
Assignee: SHINE Medical Technologies, LLC
G21G1/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,978,214
App. No.
13/575,826
Granted
Apr 13, 2021
Kind
B2
Abstract

A reactor that is operable to produce an isotope includes a region for containing a controlled nuclear fission reaction, the region segmented into a plurality of independent compartments, each of the compartments for containing a parent material in an aqueous solution that interacts with neutrons to produce the isotope via a fission reaction. Also provided are methods of producing an isotope using the same.

Claims (24)

1. A reactor operable to produce an isotope, the reactor comprising: an activation cell for containing controlled nuclear fission reactions, the activation cell segmented into n independent compartments, wherein n is an integer greater than or equal to 2, wherein the n compartments are radially disposed about a central axis of the activation cell, wherein the n compartments collectively comprise the annular activation cell that is concentrically disposed about a target chamber, wherein each of the compartments is configured for containing a parent material in an aqueous solution, wherein the parent material interacts with neutrons to produce the isotope via fission reactions in each compartment, and wherein the compartments are configured proximal to each other to facilitate neutron multiplication.

2. The reactor of claim 1 , wherein the fission reactions are maintained at a subcritical level, and driven by a neutron source.

3. The reactor of claim 2 , wherein the neutron source comprises the target chamber and an ion source, the ion source operable to produce an ion beam from a gas, wherein the target chamber contains a target, the target interacting with the ion beam to produce neutrons.

4. The reactor of claim 2 , wherein the ion source and the target chamber together at least partially define a fusion reactor.

5. The reactor of claim 1 , wherein the parent material comprises uranium.

6. The reactor of claim 5 , wherein the parent material comprises low enriched U-235.

7. The reactor of claim 1 , wherein the isotope comprises Mo-99.

8. The reactor of claim 1 , wherein the isotope comprises Mo-99, I-131, I-125, Xe-133, Cs-137, Co-60, or Sr-89.

9. The reactor of claim 1 , wherein at least two adjacent compartments share a divider.

10. The reactor of claim 9 , comprising a plurality of dividers, each divider dividing at least two adjacent compartments.

11. The reactor of claim 9 , wherein the divider physically separates the adjacent compartments.

12. The reactor of claim 1 , wherein the plurality of compartments is configured for interaction of the parent material with neutrons simultaneously in each compartment.

13. The reactor of claim 1 , wherein the compartments are circumferentially arranged in series.

14. The reactor of claim 1 , wherein the target chamber is in a concentric relationship with at least one pair of diametrically opposed compartments.

15. The reactor of claim 3 , wherein the target interacts with the ion beam to produce neutrons via a fusion reaction.

16. A reactor operable to produce an isotope, the reactor comprising:

a target chamber; and

an annular activation cell, wherein the annular activation cell is segmented into a plurality of independent compartments, each of the compartments configured for containing a parent material in an aqueous solution,

wherein the plurality of compartments collectively comprises the annular activation cell that is concentrically disposed about the target chamber,

wherein the compartments are radially disposed about a central axis of the annular activation cell and the compartments are circumferentially arranged in series,

wherein the parent material interacts with neutrons to produce the isotope via fission reactions in each compartment, and

wherein the compartments are configured proximal to each other to facilitate neutron multiplication.

17. The reactor of claim 16 , wherein the target chamber is concentric to the annular activation cell.

18. The reactor of claim 16 , wherein the fission reactions are maintained at a subcritical level and driven by a neutron source, the neutron source comprising the target chamber and an ion source, the ion source operable to produce an ion beam from a gas, and wherein the target chamber contains a target, the target interacting with the ion beam to produce neutrons via fusion reactions.

Assignments (6)
CHANGE OF NAME Recorded Oct 15, 2021
From: SHINE MEDICAL TECHNOLOGIES, LLC
To: SHINE TECHNOLOGIES, LLC
Reel/Frame 057827/0843 →
CERTIFICATE OF CONVERSION AND CHANGE OF NAME Recorded Jan 11, 2021
From: SHINE MEDICAL TECHNOLOGIES, INC.
To: SHINE MEDICAL TECHNOLOGIES, LLC
Reel/Frame 054960/0567 →
SECURITY INTEREST Recorded Nov 20, 2018
From: SHINE MEDICAL TECHNOLOGIES, INC.
To: DEERFIELD MANAGEMENT COMPANY, L.P.
Reel/Frame 047555/0830 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2012
From: MACKIE, THOMAS ROCKWELL
To: SHINE MEDICAL TECHNOLOGIES, INC.
Reel/Frame 028932/0745 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2012
From: PIEFER, GREGORY
To: PHOENIX NUCLEAR LABS LLC
Reel/Frame 028829/0145 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2012
From: PHOENIX NUCLEAR LABS LLC
To: SHINE MEDICAL TECHNOLOGIES, INC.
Reel/Frame 028829/0227 →
Continuity (2)
Provisional Application 61299258 · Jan 28, 2010
Related Publication 20120300890A1 · Nov 29, 2012
Cited By (1)
US 12,548,687